The methyaltion frequencies of 7 genes: MYF6, SIX6, SOX1, RARB, BCL2, PHOX2A and FOLX2 were significantly higher in stage I NSCLC than in non-cancerous lung diseases. This evidence concerns the gene BCL2 and non-small cell lung carcinoma.